Proefschrift

Bibliography Abrahamsson, P. (2017). Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots. Asian Journal of Urology , 4(4):208–222. 104 Adams, J. (1853). The case of scirrhous of the prostate gland with corresponding affliction of the lymphatic glands in the lumbar region and in the pelvis. Lancet , 1:393–393. 4 Administration of Radioactive Substances Advisory Committee (2006). Notes for guidance on the clinical administration of radiopharmaceuticals and the use of sealed radioactive sources . Health Protection Agency. 113 Aktipis, A., Boddy, A., Gatenby, R., Brown, J., and Maley, C. (2013). Life history trade-offs in cancer evolution. Nature Reviews Cancer , 13(12):883–892. 19 Aktipis, A., Kwan, V. S., Johnson, K., Neuberg, S., and Maley, C. (2011). Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One , 6(11):e26100. 49 Algoul, S., Alam, M., Hossain, M., and Majumder, M. (2011). Multi-objective optimal chemotherapy control model for cancer treatment. Medical & Biological Engineering & Computing , 49:51–65. 76, 109 Altrock, P., Liu, L., and Michor, F. (2015). The mathematics of cancer: integrating quantitative models. Nature Reviews Cancer , 12:730–745. 27 Amirouchene-Angelozzi, N., Swanton, C., and Bardelli, A. (2017). Tumor evolution as a therapeutic target. Cancer Discovery , 7(8):805–817. 110 Anderson, A., Rejniak, K., Gerlee, P., and Quaranta, V. (2007). Modelling of cancer growth, evolution and invasion: bridging scales and models. Mathematical Model ling of Natural Phenomena , 2(3):1–29. 27 Angel, L. (1969). The bases of paleodemography. American Journal of Physical Anthropology , 30(3):427–437. 4 165